2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Keratoderma, Palmoplantar, Diffuse: new trials by email Literature Review of Keratoderma, Palmoplantar, Diffuse trials Research Report on Keratoderma, Palmoplantar, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 604 | 2011-02-01 | 2019-04-03 |
| Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 594 | 2010-12-01 | 2019-02-22 |
Foot Dermatoses (2) · Keratoderma, Palmoplantar, Epidermolytic (2) · Nails, Malformed (2) · Onycholysis (2) · Onychomycosis (2) · Twenty-Nail Dystrophy (2) · Yellow Nail Syndrome (2)
Bacterial Infections and Mycoses (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dermatomycoses (2) · Foot Diseases (2) · Genetic Diseases, Inborn (2) · Infections (2) · Keratoderma, Palmoplantar (2) · Keratosis (2) · Mycoses (2) · Nail Diseases (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Pigmentation Disorders (2) · Skin Diseases (2)
Solutions (2)
Pfizer (2)
United States (2) · Canada (1)